SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000926617-24-000029
Filing Date
2024-04-22
Accepted
2024-04-22 17:17:56
Documents
7

Document Format Files

Seq Description Document Type Size
1 awh-20240422xs3.htm S-3 404034
2 awh-20240422xex4_8.htm EX-4.8 575447
3 awh-20240422xex5_1.htm EX-5.1 70081
4 awh-20240422xex5_1g001.jpg GRAPHIC 24621
5 awh-20240422xex23_1.htm EX-23.1 5824
6 awh-20240422xexfilingfees.htm EX-FILING FEES 231156
7 awh-20240422xs3g001.jpg GRAPHIC 10870
  Complete submission text file 0000926617-24-000029.txt   1337056
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278867 | Film No.: 24862037
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)